Biologic therapy in patients with severe psoriasis was associated with a reduction of non-calcified coronary plaque and improvement in plaque morphology, compared with patients with severe psoriasis not treated with biologic therapy, according to a study published in Cardiovascular Research...
In the News
Patients with hypertension and psoriasis more often required cardiovascular procedures and surgeries than patients with hypertension without psoriasis, according to a study published in the Journal of Dermatology.
The results suggest that patients with hypertension with concurrent...
Adherence to a Mediterranean diet, an eating plan filled with fruits and vegetables, legumes, cereals, bread, fish, fruit, nuts and extra-virgin olive oil, may be associated with the severity of psoriasis, according to a study published in Jama Dermatology.“The Mediterranean diet may slow...
Patients with cancer receiving programmed cell death protein 1 (PD-1) inhibitors who develop lesions, eczema, psoriasis, or other forms of autoimmune diseases affecting the skin may experience these adverse reactions after treatment has concluded, according to study published in JAMA...
PHILADELPHIA -- May 18, 2018 -- Adalimumab (Humira) has no effect on aortic inflammation, unlike other antibodies that target different aspects of the immune system, according to a study published in the journal Circulation: Cardiovascular Imaging.
In the study, patients with...
By Michael Bassett
SAN DIEGO -- February 22, 2018 -- The use of brodalumab to treat patients with psoriasis reduces anxiety and depression associated with the condition, according to a study presented here at the 2018 Annual Meeting of the American Academy of Dermatology (AAD).
...
PHILADELPHIA -- November 14, 2017 -- People with psoriasis have a higher risk of developing type 2 diabetes than those without psoriasis, and the risk increases dramatically based on the severity of the disease, according to a study published in the Journal of the American Academy of Dermatology...
PHILADELPHIA -- September 5, 2017 -- The more the surface area of the body is covered by psoriasis, the greater the risk of death for the patient suffering from the condition, according to a study published in the Journal of Investigative Dermatology.
The study is the first to link...
UMEÅ, Sweden -- February 2, 2017 -- One in 5 patients undergoing systemic treatment for psoriasis still have considerable problems with their disease, according to a study published in the Journal of Dermatological Treatment.
“Our results suggest that the currently available treatments...
PHILADELPHIA -- February 22, 2017 -- Patients with psoriasis who developed depression were at a 37% greater risk of subsequently developing psoriatic arthritis, compared with patients with psoriasis who did not develop depression, according to a study published in the Journal of Investigative...
Pages
Hessel H van der Zee, MD, PhD and Caitriona Ryan, MD, invite you to explore the education and resources on this site, designed to provide a comprehensive approach to managing patients with hidradenitis suppurativa.
Hessel H van der Zee, MD, PhD
Erasmus University Medical Center
Rotterdam, the Netherlands
Caitriona Ryan, MD
St. Vincent's Hospital
Dublin, Ireland
 |
User-friendly learning modules available in short and accessible formats. |
 |
Insights and developments in HS from leading experts. |
 |
Continuously updated news and conference coverage. |
 |
Helpful resources for your practice and patients. |
Resource Library
Hurley Staging Refined: A Proposal by the Dutch Hidradenitis Suppurativa Expert Group
Hidradenitis Suppurativa: From Pathogenesis to Diagnosis and Treatment
Interventions for Hidradenitis Suppurativa Updated Summary of an Original Cochrane Review
European Dermatology Forum: Guideline on Hidradenitis Suppurativa
European S1 Guideline for the Treatment of Hidradenitis Suppurativa/Acne Inversa
Canadian Hidradenitis Suppurativa Foundation
European Hidradenitis Suppurativa Foundation (EHSF) 2017